We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCUT icon
1151
Lifetime Brands
LCUT
$199M
$61.2K ﹤0.01%
12,000
EOSE icon
1152
Eos Energy Enterprises
EOSE
$1.23B
$57.3K ﹤0.01%
11,200
+1,000
+10% +$4.9K
BLZE icon
1153
Backblaze
BLZE
$697M
$55.1K ﹤0.01%
10,020
TBMCR
1154
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$51.9K ﹤0.01%
139,050
WRN
1155
Western Copper and Gold
WRN
$485M
$50K ﹤0.01%
40,000
ACCO icon
1156
Acco Brands
ACCO
$369M
$46.5K ﹤0.01%
13,000
IRBT
1157
DELISTED
iRobot
IRBT
$40.7K ﹤0.01%
13,000
-500
-4% -$1.38K
MBAVW
1158
DELISTED
M3-Brigade Acquisition V Corp Warrant
MBAVW
$37.2K ﹤0.01%
21,250
TIXT
1159
DELISTED
TELUS International
TIXT
$36.3K ﹤0.01%
+10,000
New +$28.4K
PGACR
1160
Pantages Capital Acquisition Corp Right
PGACR
$32.3K ﹤0.01%
+146,800
New +$32.5K
CDZI icon
1161
Cadiz
CDZI
$266M
$29.9K ﹤0.01%
10,000
ONL
1162
Orion Office REIT
ONL
$148M
$25.6K ﹤0.01%
+12,000
New +$22.9K
HBIO icon
1163
Harvard Bioscience
HBIO
$27.1M
$22.2K ﹤0.01%
5,000
-1,500
-23% -$6.27K
SVIIR
1164
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$21.9K ﹤0.01%
156,550
RIBBR
1165
Ribbon Acquisition Corp Rights
RIBBR
$21.9K ﹤0.01%
+105,800
New +$21.1K
FTW.WS
1166
Presidio Production Co Warrants
FTW.WS
$20.8K ﹤0.01%
28,300
COLAR
1167
Columbus Acquisition Corp Rights
COLAR
$19.4K ﹤0.01%
+105,300
New +$22.4K
EURKR
1168
Eureka Acquisition Corp Right
EURKR
$17K ﹤0.01%
72,300
ESHAR
1169
DELISTED
ESH Acquisition Corp Right
ESHAR
$16.7K ﹤0.01%
227,150
AP.WS
1170
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
$15.1K ﹤0.01%
794,000
-6,000
-0.8% -$142
CCIXW
1171
Churchill Capital Corp IX Warrant
CCIXW
$71.9K
$14.1K ﹤0.01%
+14,797
New +$13.9K
SUP
1172
DELISTED
Superior Industries International
SUP
$13.4K ﹤0.01%
98,000
-2,000
-2% -$2.75K
ASPCR
1173
A SPAC III Acquisition Corp Right
ASPCR
$12.2K ﹤0.01%
+71,800
New +$11.6K
DISTR
1174
DELISTED
Distoken Acquisition Corporation Right
DISTR
$11.8K ﹤0.01%
40,700
SVIIW
1175
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$11K ﹤0.01%
78,275

Similar funds

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.